S&P 500   2,746.90 (+3.29%)
DOW   23,386.11 (+3.23%)
QQQ   200.41 (+2.04%)
AAPL   265.69 (+2.41%)
FB   173.83 (+2.96%)
MSFT   165.38 (+1.16%)
GOOGL   1,209.87 (+2.31%)
AMZN   2,037.00 (+1.26%)
CGC   14.96 (+3.24%)
NVDA   266.75 (+2.98%)
BABA   195.10 (-1.46%)
MU   48.48 (+4.17%)
GE   7.30 (+3.84%)
TSLA   546.44 (+0.18%)
AMD   48.83 (+2.67%)
T   29.72 (-1.20%)
ACB   0.86 (+7.50%)
F   5.03 (+6.80%)
BAC   23.36 (+5.51%)
GILD   74.67 (+0.00%)
DIS   100.52 (-0.71%)
PRI   97.04 (+10.20%)
S&P 500   2,746.90 (+3.29%)
DOW   23,386.11 (+3.23%)
QQQ   200.41 (+2.04%)
AAPL   265.69 (+2.41%)
FB   173.83 (+2.96%)
MSFT   165.38 (+1.16%)
GOOGL   1,209.87 (+2.31%)
AMZN   2,037.00 (+1.26%)
CGC   14.96 (+3.24%)
NVDA   266.75 (+2.98%)
BABA   195.10 (-1.46%)
MU   48.48 (+4.17%)
GE   7.30 (+3.84%)
TSLA   546.44 (+0.18%)
AMD   48.83 (+2.67%)
T   29.72 (-1.20%)
ACB   0.86 (+7.50%)
F   5.03 (+6.80%)
BAC   23.36 (+5.51%)
GILD   74.67 (+0.00%)
DIS   100.52 (-0.71%)
PRI   97.04 (+10.20%)
S&P 500   2,746.90 (+3.29%)
DOW   23,386.11 (+3.23%)
QQQ   200.41 (+2.04%)
AAPL   265.69 (+2.41%)
FB   173.83 (+2.96%)
MSFT   165.38 (+1.16%)
GOOGL   1,209.87 (+2.31%)
AMZN   2,037.00 (+1.26%)
CGC   14.96 (+3.24%)
NVDA   266.75 (+2.98%)
BABA   195.10 (-1.46%)
MU   48.48 (+4.17%)
GE   7.30 (+3.84%)
TSLA   546.44 (+0.18%)
AMD   48.83 (+2.67%)
T   29.72 (-1.20%)
ACB   0.86 (+7.50%)
F   5.03 (+6.80%)
BAC   23.36 (+5.51%)
GILD   74.67 (+0.00%)
DIS   100.52 (-0.71%)
PRI   97.04 (+10.20%)
S&P 500   2,746.90 (+3.29%)
DOW   23,386.11 (+3.23%)
QQQ   200.41 (+2.04%)
AAPL   265.69 (+2.41%)
FB   173.83 (+2.96%)
MSFT   165.38 (+1.16%)
GOOGL   1,209.87 (+2.31%)
AMZN   2,037.00 (+1.26%)
CGC   14.96 (+3.24%)
NVDA   266.75 (+2.98%)
BABA   195.10 (-1.46%)
MU   48.48 (+4.17%)
GE   7.30 (+3.84%)
TSLA   546.44 (+0.18%)
AMD   48.83 (+2.67%)
T   29.72 (-1.20%)
ACB   0.86 (+7.50%)
F   5.03 (+6.80%)
BAC   23.36 (+5.51%)
GILD   74.67 (+0.00%)
DIS   100.52 (-0.71%)
PRI   97.04 (+10.20%)
Log in

NASDAQ:IRTCIrhythm Technologies Stock Price, Forecast & News

$79.90
+4.84 (+6.45 %)
(As of 04/8/2020 03:14 PM ET)
Add
Compare
Today's Range
$75.53
Now: $79.90
$80.07
50-Day Range
$57.79
MA: $82.42
$101.40
52-Week Range
$56.24
Now: $79.90
$104.25
Volume17,849 shs
Average Volume404,643 shs
Market Capitalization$2.14 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.22
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.
Read More
Irhythm Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.47 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRTC
CUSIPN/A
Phone415-632-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$214.55 million
Book Value$5.09 per share

Profitability

Net Income$-54,570,000.00

Miscellaneous

Employees748
Market Cap$2.14 billion
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.


Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

How has Irhythm Technologies' stock been impacted by COVID-19 (Coronavirus)?

Irhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IRTC stock has decreased by 6.5% and is now trading at $79.99. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Irhythm Technologies?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Irhythm Technologies.

When is Irhythm Technologies' next earnings date?

Irhythm Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Irhythm Technologies.

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) issued its quarterly earnings results on Thursday, February, 27th. The company reported ($0.65) EPS for the quarter, missing the consensus estimate of ($0.53) by $0.12. The business had revenue of $59.10 million for the quarter, compared to the consensus estimate of $58.42 million. Irhythm Technologies had a negative net margin of 25.69% and a negative return on equity of 58.88%. The company's revenue was up 41.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.61) EPS. View Irhythm Technologies' earnings history.

What guidance has Irhythm Technologies issued on next quarter's earnings?

Irhythm Technologies updated its FY 2020 After-Hours earnings guidance on Thursday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $280-290 million, compared to the consensus revenue estimate of $283.61 million.

What price target have analysts set for IRTC?

8 analysts have issued 1 year price targets for Irhythm Technologies' stock. Their forecasts range from $90.00 to $125.00. On average, they expect Irhythm Technologies' share price to reach $109.17 in the next year. This suggests a possible upside of 36.5% from the stock's current price. View analysts' price targets for Irhythm Technologies.

Has Irhythm Technologies been receiving favorable news coverage?

Media headlines about IRTC stock have trended very negative recently, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Irhythm Technologies earned a news impact score of -3.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutIrhythm Technologies.

Are investors shorting Irhythm Technologies?

Irhythm Technologies saw a drop in short interest in March. As of March 13th, there was short interest totaling 4,970,700 shares, a drop of 14.7% from the February 27th total of 5,830,000 shares. Based on an average daily trading volume, of 469,900 shares, the short-interest ratio is presently 10.6 days. Approximately 20.9% of the shares of the stock are short sold. View Irhythm Technologies' Current Options Chain.

Who are some of Irhythm Technologies' key competitors?

What other stocks do shareholders of Irhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Square (SQ), Splunk (SPLK), Twilio (TWLO), DexCom (DXCM), Paypal (PYPL), Cisco Systems (CSCO), Tandem Diabetes Care (TNDM) and Canopy Growth (CGC).

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the following people:
  • Mr. Kevin M. King, Pres, CEO & Director (Age 63)
  • Mr. Matthew C. Garrett, Chief Financial Officer (Age 51)
  • Mr. David A. Vort, Exec. VP of Sales (Age 53)
  • Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Karim Karti, Chief Operating Officer (Age 50)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

How do I buy shares of Irhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $79.99.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $2.14 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe. View additional information about Irhythm Technologies.

What is Irhythm Technologies' official website?

The official website for Irhythm Technologies is http://www.irhythmtech.com/.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, SAN FRANCISCO CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]

This page was last updated on 4/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel